Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?

par Zang, Rongyu, Zhu, Jianqing
Publié dans J Gynecol Oncol (2019)

The 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean Gynecologic Oncology Group (KGOG) joint meeting and 2016 Asia-Pacific Ovarian cancer Laparotomy and Laparoscopic Operation...

par Chang, Ha Kyun, Kim, Byoung-Gie, Shi, Ting-Yan, Zang, Rongyu
Publié dans J Gynecol Oncol (2016)

The prognosis of women with stage IB1-IIB node-positive cervical carcinoma after radical surgery

par Cheng, Xi, Cai, Shumo, Li, Ziting, Tang, Meiqin, Xue, Muquan, Zang, Rongyu
Publié 2004

Can 9q34.2 rs633862 polymorphism predict survival in epithelial ovarian cancer?

par Jiang, Rong, Xu, Yuan, Wang, Pan, Cheng, Xi, Shi, Tingyan, Zang, Rongyu
Publié dans PeerJ (2017)

Cancer-Associated Fibroblast-Derived Interleukin-8 Promotes Ovarian Cancer Cell Stemness and Malignancy Through the Notch3-Mediated Signaling

par Ji, Zhaodong, Tian, Wenjuan, Gao, Wen, Zang, Rongyu, Wang, Huaying, Yang, Gong
Publié dans Front Cell Dev Biol (2021)

Current status of gynecological cancer in China

par Kim, Kidong, Zang, Rongyu, Choi, Seok-Cheol, Ryu, Sang-Young, Kim, Jae Weon
Publié 2009

Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancer

par Shi, Tingyan, Jiang, Rong, Wang, Pan, Xu, Yuan, Yin, Sheng, Cheng, Xi, Zang, Rongyu
Publié dans Onco Targets Ther (2017)

Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational study

par Ren, Yulan, Jiang, Rong, Yin, Sheng, You, Chao, Liu, Dongli, Cheng, Xi, Tang, Jie, Zang, Rongyu
Publié dans BMC Cancer (2015)

AGO1 may influence the prognosis of hepatocellular carcinoma through TGF-β pathway

par Wang, Miao, Zhang, Lyu, Liu, Zeyang, Zhou, Jiamin, Pan, Qi, Fan, Jia, Zang, Rongyu, Wang, Lu
Publié dans Cell Death Dis (2018)

Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis

par Wang, Ziliang, Liu, Yang, Lu, Lili, Yang, Lina, Yin, Sheng, Wang, Yan, Qi, Zihao, Meng, Jiao, Zang, Rongyu, Yang, Gong
Publié dans Oncotarget (2015)

The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy

par Wang, Yan, Wang, Ziliang, Qi, Zihao, Yin, Sheng, Zhang, Na, Liu, Yang, Liu, Mingming, Meng, Jiao, Zang, Rongyu, Zhang, Zhen, Yang, Gong
Publié 2014

An improved nerve-sparing radical hysterectomy technique for cervical cancer using the paravesico-vaginal space as a new surgical landmark

par Zhang, Yuqin, Shi, Tingyan, Yin, Sheng, Ma, Sining, Shi, Di, Guan, Jun, Xiang, Libing, Liu, Yang, Ren, Yulan, Tan, Deyan, Zang, Rongyu
Publié dans Oncotarget (2017)

Wip1 suppresses ovarian cancer metastasis through the ATM/AKT/Snail mediated signaling

par Yin, Sheng, Wang, Pan, Yang, Lina, Liu, Yang, Wang, Yan, Liu, Mingming, Qi, Zihao, Meng, Jiao, Shi, Ting-Yan, Yang, Gong, Zang, Rongyu
Publié dans Oncotarget (2016)

Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial

par Shi, Tingyan, Jiang, Rong, Yu, Jinjin, Yang, Huijuan, Tu, Dongsheng, Dai, Zhiyuan, Shen, Yang, Zhang, Yuqin, Cheng, Xi, Jia, Huixun, Tu, Ruiqin, Wang, Huaying, Tang, Jie, Luan, Yuting, Cai, Shumo, Zang, Rongyu
Publié dans Br J Cancer (2018)

Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study

par Shi, Tingyan, Jiang, Rong, Pu, Hong, Yang, Huijuan, Tu, Dongsheng, Dai, Zhiyuan, Cai, Yunlang, Zhang, Yuqin, Cheng, Xi, Jia, Huixun, Tu, Ruiqin, Wang, Huaying, Tang, Jie, Luan, Yuting, Cai, Shumo, Zang, Rongyu
Publié dans Br J Cancer (2019)

Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept

par Jiang, Rong, Zhu, Jianqing, Kim, Jae-Weon, Liu, Jihong, Kato, Kazuyoshi, Kim, Hee-Seung, Zhang, Yuqin, Zhang, Ping, Zhu, Tao, Aoki, Daisuke, Yu, Aijun, Chen, Xiaojun, Wang, Xipeng, Zhu, Ding, Zhang, Wei, Jia, Huixun, Shi, Tingyan, Gao, Wen, Yin, Sheng, Feng, Yanling, Xiang, Libing, Okamoto, Aikou, Zang, Rongyu
Publié dans J Gynecol Oncol (2020)

A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study

par Shi, Tingyan, Yin, Sheng, Zhu, Jianqing, Zhang, Ping, Liu, Jihong, Xiang, Libing, Zhu, Yaping, Wu, Sufang, Chen, Xiaojun, Wang, Xipeng, Teng, Yincheng, Zhu, Tao, Yu, Aijun, Zhang, Yingli, Feng, Yanling, Huang, He, Bao, Wei, Li, Yanli, Jiang, Wei, Zhang, Ping, Li, Jiarui, Ai, Zhihong, Zhang, Wei, Jia, Huixun, Zhang, Yuqin, Jiang, Rong, Zhang, Jiejie, Gao, Wen, Luan, Yuting, Zang, Rongyu
Publié dans J Gynecol Oncol (2020)